News
STIM
1.430
-11.73%
-0.190
Neuronetics Announces Public Offering to Repay Debt
TipRanks · 12h ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 1d ago
Neuronetics Stock Declines on Underwritten Public Offering Aimed at Resolving Going Concern Risk
Dow Jones · 1d ago
Neuronetics 18.75M share Spot Secondary priced at $1.60
TipRanks · 1d ago
Neuronetics Prices $30 Mln Offering Of Shares At $1.60/Shr; Plans Debt Repayment; Stock Down
NASDAQ · 1d ago
Neuronetics prices $30M public offering, shares slide 13%
Seeking Alpha · 1d ago
*Neuronetics Announces Underwritten Public Offering of 18.75M Shares at $1.60 Per Share>STIM
Dow Jones · 1d ago
*Neuronetics: To Use Proceeds to Repay Portion of Outstanding Debt, General Corporate Purposes >STIM
Dow Jones · 1d ago
*Neuronetics: Gross Proceeds Expected to Be Approximately $30M >STIM
Dow Jones · 1d ago
*Neuronetics: Offering Expected to Close on or About Nov. 12 >STIM
Dow Jones · 1d ago
*Neuronetics: Granted Underwriters 30-Day Option to Purchase Up to 2.8M Shares at Public Offering Price Per Share >STIM
Dow Jones · 1d ago
*Neuronetics Prices $30 Million Underwritten Public Offering of Common Stock
Dow Jones · 1d ago
Neuronetics Amends Credit Agreement and Revenue Covenants
TipRanks · 2d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2d ago
Neuronetics Announces Credit Agreement Amendments And Public Offering Of Shares; Size Not Disclosed
Benzinga · 2d ago
Neuronetics falls in after-hours after launching a public stock offering
Seeking Alpha · 2d ago
Neuronetics announces common stock offering, no amount given
TipRanks · 2d ago
Weekly Report: what happened at STIM last week (1102-1106)?
Weekly Report · 3d ago
Neuronetics Is Maintained at Buy by B. Riley Securities
Dow Jones · 6d ago
Neuronetics Price Target Raised to $6.00/Share From $5.00 by B. Riley Securities
Dow Jones · 6d ago
More
Webull provides a variety of real-time STIM stock news. You can receive the latest news about Neuronetics through multiple platforms. This information may help you make smarter investment decisions.
About STIM
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.